Multi-center clinical studies for strategies to improve patients' accessibility to peginterferon therapy: Consideration based on both prospective study and retrospective study

To evaluate whether start-up of peginterferon therapy for chronic hepatitis C at out-patient clinic may improve patients' accessibility, multi-center clinical studies were performed. In retrospective study with 879 patients who had already finished peginterferon (plus ribavirin) therapy, adhere...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kanzo 2010, Vol.51(7), pp.348-360
Hauptverfasser: Masaki, Naohiko, Nishimura, Sou, Inbe, Kou, Yamada, Akihiro, Yanase, Mikio, Yano, Kouji, Itoh, Kiyoaki, Imamura, Masatoshi, Itoh, Kazuki, Gibo, Yukio, Kaito, Masahiko, Kawakami, Yoshiiku, Kawakami, Hiroiku, Hatakeyama, Shigeaki, Komatsu, Masafumi, Kim, Soo Ryang, Yatsuhashi, Hiroshi, Izumi, Namiki, Nomura, Hideyuki, Saibara, Toshiji, Nakao, Haruhisa, Yoneda, Masashi, Hiramatsu, Naoki, Hayashi, Norio, Mizokami, Masashi
Format: Artikel
Sprache:jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 360
container_issue 7
container_start_page 348
container_title Kanzo
container_volume 51
creator Masaki, Naohiko
Nishimura, Sou
Inbe, Kou
Yamada, Akihiro
Yanase, Mikio
Yano, Kouji
Itoh, Kiyoaki
Imamura, Masatoshi
Itoh, Kazuki
Gibo, Yukio
Kaito, Masahiko
Kawakami, Yoshiiku
Kawakami, Hiroiku
Hatakeyama, Shigeaki
Komatsu, Masafumi
Kim, Soo Ryang
Yatsuhashi, Hiroshi
Izumi, Namiki
Nomura, Hideyuki
Saibara, Toshiji
Nakao, Haruhisa
Yoneda, Masashi
Hiramatsu, Naoki
Hayashi, Norio
Mizokami, Masashi
description To evaluate whether start-up of peginterferon therapy for chronic hepatitis C at out-patient clinic may improve patients' accessibility, multi-center clinical studies were performed. In retrospective study with 879 patients who had already finished peginterferon (plus ribavirin) therapy, adherence to treatment regimen and final virological response were quite similar in both modes of start-up (at hospitalization or at out-patient clinic). In addition, interruption rate was rather lower in patients with start-up at out-patient clinic than in those at hospitalization. In prospective study, unsigned questionnaires about modes of start-up were carried out. Twenty-two out of 38 (58%) patients who started up peginterferon therapy at hospitalization preferred shorter hospital stays or start-up at out-patient clinic. In contrast, fifty-nine out of 73 (81%) patients who started up at out-patient clinic were completely satisfied. These lines of evidence may suggest start-up at out-patient clinic is fully safe and improves patients' accessibility to peginterferon therapy.
doi_str_mv 10.2957/kanzo.51.348
format Article
fullrecord <record><control><sourceid>jstage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_2957_kanzo_51_348</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>article_kanzo_51_7_51_7_348_article_char_en</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2468-844eff1955a3b329fc25e88e4a45e0b672b0f761598a5a35ca4e0dc3e6df559d3</originalsourceid><addsrcrecordid>eNpdkMtOwzAQRS0EEhV0xwd4x4YUO7bzYFdVvKQiNrCOJs64NaRJZLtI5af4RRyKisTG8_CZO6NLyAVns7RU-fU7dJ_9TPGZkMURmfCi4IlQpTgmEyYVT2TKxCmZem9rxtIsZ2WZTsjX07YNNtHYBXRUt7azGlrqw7ax6KnpXcwdBFyNZeip3Qyu_0A6QLBxyF9S0BpHVdvasBuRIcKjnEHXdzSs0cGwu6GLvvO2iUWwsV2Dx4aOSR_WNGr6AXWwUXncvaPQNdRh-N8_JycGWo_T33hGXu9uXxYPyfL5_nExXyY6lVmRFFKiMbxUCkQt0tLoVGFRoASpkNVZntbM5BlXZQERURokskYLzBqjVNmIM3K119XxAu_QVIOzG3C7irNq9Lv68btSvIp-R3y-x998gBUeYHDB6hb_4Hz_xJnDn16Dq7AT39-GkvI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Multi-center clinical studies for strategies to improve patients' accessibility to peginterferon therapy: Consideration based on both prospective study and retrospective study</title><source>J-STAGE Free</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Masaki, Naohiko ; Nishimura, Sou ; Inbe, Kou ; Yamada, Akihiro ; Yanase, Mikio ; Yano, Kouji ; Itoh, Kiyoaki ; Imamura, Masatoshi ; Itoh, Kazuki ; Gibo, Yukio ; Kaito, Masahiko ; Kawakami, Yoshiiku ; Kawakami, Hiroiku ; Hatakeyama, Shigeaki ; Komatsu, Masafumi ; Kim, Soo Ryang ; Yatsuhashi, Hiroshi ; Izumi, Namiki ; Nomura, Hideyuki ; Saibara, Toshiji ; Nakao, Haruhisa ; Yoneda, Masashi ; Hiramatsu, Naoki ; Hayashi, Norio ; Mizokami, Masashi</creator><creatorcontrib>Masaki, Naohiko ; Nishimura, Sou ; Inbe, Kou ; Yamada, Akihiro ; Yanase, Mikio ; Yano, Kouji ; Itoh, Kiyoaki ; Imamura, Masatoshi ; Itoh, Kazuki ; Gibo, Yukio ; Kaito, Masahiko ; Kawakami, Yoshiiku ; Kawakami, Hiroiku ; Hatakeyama, Shigeaki ; Komatsu, Masafumi ; Kim, Soo Ryang ; Yatsuhashi, Hiroshi ; Izumi, Namiki ; Nomura, Hideyuki ; Saibara, Toshiji ; Nakao, Haruhisa ; Yoneda, Masashi ; Hiramatsu, Naoki ; Hayashi, Norio ; Mizokami, Masashi</creatorcontrib><description>To evaluate whether start-up of peginterferon therapy for chronic hepatitis C at out-patient clinic may improve patients' accessibility, multi-center clinical studies were performed. In retrospective study with 879 patients who had already finished peginterferon (plus ribavirin) therapy, adherence to treatment regimen and final virological response were quite similar in both modes of start-up (at hospitalization or at out-patient clinic). In addition, interruption rate was rather lower in patients with start-up at out-patient clinic than in those at hospitalization. In prospective study, unsigned questionnaires about modes of start-up were carried out. Twenty-two out of 38 (58%) patients who started up peginterferon therapy at hospitalization preferred shorter hospital stays or start-up at out-patient clinic. In contrast, fifty-nine out of 73 (81%) patients who started up at out-patient clinic were completely satisfied. These lines of evidence may suggest start-up at out-patient clinic is fully safe and improves patients' accessibility to peginterferon therapy.</description><identifier>ISSN: 0451-4203</identifier><identifier>EISSN: 1881-3593</identifier><identifier>DOI: 10.2957/kanzo.51.348</identifier><language>jpn</language><publisher>The Japan Society of Hepatology</publisher><subject>chronic hepatitis C ; peginterferon ; ribavirin ; start-up at hospitalization ; start-up at out-patient clinic</subject><ispartof>Kanzo, 2010, Vol.51(7), pp.348-360</ispartof><rights>2010 The Japan Society of Hepatology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2468-844eff1955a3b329fc25e88e4a45e0b672b0f761598a5a35ca4e0dc3e6df559d3</citedby><cites>FETCH-LOGICAL-c2468-844eff1955a3b329fc25e88e4a45e0b672b0f761598a5a35ca4e0dc3e6df559d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27900,27901,27902</link.rule.ids></links><search><creatorcontrib>Masaki, Naohiko</creatorcontrib><creatorcontrib>Nishimura, Sou</creatorcontrib><creatorcontrib>Inbe, Kou</creatorcontrib><creatorcontrib>Yamada, Akihiro</creatorcontrib><creatorcontrib>Yanase, Mikio</creatorcontrib><creatorcontrib>Yano, Kouji</creatorcontrib><creatorcontrib>Itoh, Kiyoaki</creatorcontrib><creatorcontrib>Imamura, Masatoshi</creatorcontrib><creatorcontrib>Itoh, Kazuki</creatorcontrib><creatorcontrib>Gibo, Yukio</creatorcontrib><creatorcontrib>Kaito, Masahiko</creatorcontrib><creatorcontrib>Kawakami, Yoshiiku</creatorcontrib><creatorcontrib>Kawakami, Hiroiku</creatorcontrib><creatorcontrib>Hatakeyama, Shigeaki</creatorcontrib><creatorcontrib>Komatsu, Masafumi</creatorcontrib><creatorcontrib>Kim, Soo Ryang</creatorcontrib><creatorcontrib>Yatsuhashi, Hiroshi</creatorcontrib><creatorcontrib>Izumi, Namiki</creatorcontrib><creatorcontrib>Nomura, Hideyuki</creatorcontrib><creatorcontrib>Saibara, Toshiji</creatorcontrib><creatorcontrib>Nakao, Haruhisa</creatorcontrib><creatorcontrib>Yoneda, Masashi</creatorcontrib><creatorcontrib>Hiramatsu, Naoki</creatorcontrib><creatorcontrib>Hayashi, Norio</creatorcontrib><creatorcontrib>Mizokami, Masashi</creatorcontrib><title>Multi-center clinical studies for strategies to improve patients' accessibility to peginterferon therapy: Consideration based on both prospective study and retrospective study</title><title>Kanzo</title><addtitle>Kanzo</addtitle><description>To evaluate whether start-up of peginterferon therapy for chronic hepatitis C at out-patient clinic may improve patients' accessibility, multi-center clinical studies were performed. In retrospective study with 879 patients who had already finished peginterferon (plus ribavirin) therapy, adherence to treatment regimen and final virological response were quite similar in both modes of start-up (at hospitalization or at out-patient clinic). In addition, interruption rate was rather lower in patients with start-up at out-patient clinic than in those at hospitalization. In prospective study, unsigned questionnaires about modes of start-up were carried out. Twenty-two out of 38 (58%) patients who started up peginterferon therapy at hospitalization preferred shorter hospital stays or start-up at out-patient clinic. In contrast, fifty-nine out of 73 (81%) patients who started up at out-patient clinic were completely satisfied. These lines of evidence may suggest start-up at out-patient clinic is fully safe and improves patients' accessibility to peginterferon therapy.</description><subject>chronic hepatitis C</subject><subject>peginterferon</subject><subject>ribavirin</subject><subject>start-up at hospitalization</subject><subject>start-up at out-patient clinic</subject><issn>0451-4203</issn><issn>1881-3593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNpdkMtOwzAQRS0EEhV0xwd4x4YUO7bzYFdVvKQiNrCOJs64NaRJZLtI5af4RRyKisTG8_CZO6NLyAVns7RU-fU7dJ_9TPGZkMURmfCi4IlQpTgmEyYVT2TKxCmZem9rxtIsZ2WZTsjX07YNNtHYBXRUt7azGlrqw7ax6KnpXcwdBFyNZeip3Qyu_0A6QLBxyF9S0BpHVdvasBuRIcKjnEHXdzSs0cGwu6GLvvO2iUWwsV2Dx4aOSR_WNGr6AXWwUXncvaPQNdRh-N8_JycGWo_T33hGXu9uXxYPyfL5_nExXyY6lVmRFFKiMbxUCkQt0tLoVGFRoASpkNVZntbM5BlXZQERURokskYLzBqjVNmIM3K119XxAu_QVIOzG3C7irNq9Lv68btSvIp-R3y-x998gBUeYHDB6hb_4Hz_xJnDn16Dq7AT39-GkvI</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Masaki, Naohiko</creator><creator>Nishimura, Sou</creator><creator>Inbe, Kou</creator><creator>Yamada, Akihiro</creator><creator>Yanase, Mikio</creator><creator>Yano, Kouji</creator><creator>Itoh, Kiyoaki</creator><creator>Imamura, Masatoshi</creator><creator>Itoh, Kazuki</creator><creator>Gibo, Yukio</creator><creator>Kaito, Masahiko</creator><creator>Kawakami, Yoshiiku</creator><creator>Kawakami, Hiroiku</creator><creator>Hatakeyama, Shigeaki</creator><creator>Komatsu, Masafumi</creator><creator>Kim, Soo Ryang</creator><creator>Yatsuhashi, Hiroshi</creator><creator>Izumi, Namiki</creator><creator>Nomura, Hideyuki</creator><creator>Saibara, Toshiji</creator><creator>Nakao, Haruhisa</creator><creator>Yoneda, Masashi</creator><creator>Hiramatsu, Naoki</creator><creator>Hayashi, Norio</creator><creator>Mizokami, Masashi</creator><general>The Japan Society of Hepatology</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2010</creationdate><title>Multi-center clinical studies for strategies to improve patients' accessibility to peginterferon therapy: Consideration based on both prospective study and retrospective study</title><author>Masaki, Naohiko ; Nishimura, Sou ; Inbe, Kou ; Yamada, Akihiro ; Yanase, Mikio ; Yano, Kouji ; Itoh, Kiyoaki ; Imamura, Masatoshi ; Itoh, Kazuki ; Gibo, Yukio ; Kaito, Masahiko ; Kawakami, Yoshiiku ; Kawakami, Hiroiku ; Hatakeyama, Shigeaki ; Komatsu, Masafumi ; Kim, Soo Ryang ; Yatsuhashi, Hiroshi ; Izumi, Namiki ; Nomura, Hideyuki ; Saibara, Toshiji ; Nakao, Haruhisa ; Yoneda, Masashi ; Hiramatsu, Naoki ; Hayashi, Norio ; Mizokami, Masashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2468-844eff1955a3b329fc25e88e4a45e0b672b0f761598a5a35ca4e0dc3e6df559d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>2010</creationdate><topic>chronic hepatitis C</topic><topic>peginterferon</topic><topic>ribavirin</topic><topic>start-up at hospitalization</topic><topic>start-up at out-patient clinic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Masaki, Naohiko</creatorcontrib><creatorcontrib>Nishimura, Sou</creatorcontrib><creatorcontrib>Inbe, Kou</creatorcontrib><creatorcontrib>Yamada, Akihiro</creatorcontrib><creatorcontrib>Yanase, Mikio</creatorcontrib><creatorcontrib>Yano, Kouji</creatorcontrib><creatorcontrib>Itoh, Kiyoaki</creatorcontrib><creatorcontrib>Imamura, Masatoshi</creatorcontrib><creatorcontrib>Itoh, Kazuki</creatorcontrib><creatorcontrib>Gibo, Yukio</creatorcontrib><creatorcontrib>Kaito, Masahiko</creatorcontrib><creatorcontrib>Kawakami, Yoshiiku</creatorcontrib><creatorcontrib>Kawakami, Hiroiku</creatorcontrib><creatorcontrib>Hatakeyama, Shigeaki</creatorcontrib><creatorcontrib>Komatsu, Masafumi</creatorcontrib><creatorcontrib>Kim, Soo Ryang</creatorcontrib><creatorcontrib>Yatsuhashi, Hiroshi</creatorcontrib><creatorcontrib>Izumi, Namiki</creatorcontrib><creatorcontrib>Nomura, Hideyuki</creatorcontrib><creatorcontrib>Saibara, Toshiji</creatorcontrib><creatorcontrib>Nakao, Haruhisa</creatorcontrib><creatorcontrib>Yoneda, Masashi</creatorcontrib><creatorcontrib>Hiramatsu, Naoki</creatorcontrib><creatorcontrib>Hayashi, Norio</creatorcontrib><creatorcontrib>Mizokami, Masashi</creatorcontrib><collection>CrossRef</collection><jtitle>Kanzo</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Masaki, Naohiko</au><au>Nishimura, Sou</au><au>Inbe, Kou</au><au>Yamada, Akihiro</au><au>Yanase, Mikio</au><au>Yano, Kouji</au><au>Itoh, Kiyoaki</au><au>Imamura, Masatoshi</au><au>Itoh, Kazuki</au><au>Gibo, Yukio</au><au>Kaito, Masahiko</au><au>Kawakami, Yoshiiku</au><au>Kawakami, Hiroiku</au><au>Hatakeyama, Shigeaki</au><au>Komatsu, Masafumi</au><au>Kim, Soo Ryang</au><au>Yatsuhashi, Hiroshi</au><au>Izumi, Namiki</au><au>Nomura, Hideyuki</au><au>Saibara, Toshiji</au><au>Nakao, Haruhisa</au><au>Yoneda, Masashi</au><au>Hiramatsu, Naoki</au><au>Hayashi, Norio</au><au>Mizokami, Masashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multi-center clinical studies for strategies to improve patients' accessibility to peginterferon therapy: Consideration based on both prospective study and retrospective study</atitle><jtitle>Kanzo</jtitle><addtitle>Kanzo</addtitle><date>2010</date><risdate>2010</risdate><volume>51</volume><issue>7</issue><spage>348</spage><epage>360</epage><pages>348-360</pages><issn>0451-4203</issn><eissn>1881-3593</eissn><abstract>To evaluate whether start-up of peginterferon therapy for chronic hepatitis C at out-patient clinic may improve patients' accessibility, multi-center clinical studies were performed. In retrospective study with 879 patients who had already finished peginterferon (plus ribavirin) therapy, adherence to treatment regimen and final virological response were quite similar in both modes of start-up (at hospitalization or at out-patient clinic). In addition, interruption rate was rather lower in patients with start-up at out-patient clinic than in those at hospitalization. In prospective study, unsigned questionnaires about modes of start-up were carried out. Twenty-two out of 38 (58%) patients who started up peginterferon therapy at hospitalization preferred shorter hospital stays or start-up at out-patient clinic. In contrast, fifty-nine out of 73 (81%) patients who started up at out-patient clinic were completely satisfied. These lines of evidence may suggest start-up at out-patient clinic is fully safe and improves patients' accessibility to peginterferon therapy.</abstract><pub>The Japan Society of Hepatology</pub><doi>10.2957/kanzo.51.348</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0451-4203
ispartof Kanzo, 2010, Vol.51(7), pp.348-360
issn 0451-4203
1881-3593
language jpn
recordid cdi_crossref_primary_10_2957_kanzo_51_348
source J-STAGE Free; EZB-FREE-00999 freely available EZB journals
subjects chronic hepatitis C
peginterferon
ribavirin
start-up at hospitalization
start-up at out-patient clinic
title Multi-center clinical studies for strategies to improve patients' accessibility to peginterferon therapy: Consideration based on both prospective study and retrospective study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T18%3A39%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multi-center%20clinical%20studies%20for%20strategies%20to%20improve%20patients'%20accessibility%20to%20peginterferon%20therapy:%20Consideration%20based%20on%20both%20prospective%20study%20and%20retrospective%20study&rft.jtitle=Kanzo&rft.au=Masaki,%20Naohiko&rft.date=2010&rft.volume=51&rft.issue=7&rft.spage=348&rft.epage=360&rft.pages=348-360&rft.issn=0451-4203&rft.eissn=1881-3593&rft_id=info:doi/10.2957/kanzo.51.348&rft_dat=%3Cjstage_cross%3Earticle_kanzo_51_7_51_7_348_article_char_en%3C/jstage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true